Stay updated on Nivolumab vs Temozolomide in GBM Clinical Trial
Sign up to get notified when there's something new on the Nivolumab vs Temozolomide in GBM Clinical Trial page.

Latest updates to the Nivolumab vs Temozolomide in GBM Clinical Trial page
- Check3 days agoChange DetectedThe page revision was updated from v3.6.2 to v3.6.3, representing a small update to the study record and related documentation.SummaryDifference0.0%

- Check10 days agoChange DetectedSoftware revision updated from v3.6.0 to v3.6.2, a minor version bump without changes to the study details or page content.SummaryDifference0.0%

- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedThe study page now indicates recruitment has ended for participants. New help/navigation items were added (How to Read a Study Record, Common Questions, How to Join a Study), and the Intervention/Treatment heading was reformatted while the revision version was updated to v3.6.0.SummaryDifference0.2%

- Check32 days agoChange DetectedThe page’s revision tag was updated from v3.5.4 to v3.5.5, indicating a minor metadata update rather than a change to the study information.SummaryDifference0.0%

- Check53 days agoChange DetectedRevision: v3.5.4 has been added and the previous Revision: v3.5.3 has been removed on the page. This reflects an internal update to the page’s versioning label rather than a change to user-facing content or functionality.SummaryDifference0.0%

- Check75 days agoChange DetectedThe page’s site footer version has been updated from **v3.5.2** to **v3.5.3**, indicating a minor platform/content delivery revision rather than any change to the study record.SummaryDifference0.0%

Stay in the know with updates to Nivolumab vs Temozolomide in GBM Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab vs Temozolomide in GBM Clinical Trial page.